Literature DB >> 1284474

Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome.

M A Berg1, J Guevara-Aguirre, A L Rosenbloom, R G Rosenfeld, U Francke.   

Abstract

Laron syndrome is an autosomal recessive condition characterized by resistance to growth hormone. We sought to determine the molecular basis of this condition in an Ecuadorean population with a high incidence of affected individuals. Growth hormone receptor gene sequences from an obligate heterozygote were amplified by the polymerase chain reaction and screened for mutations using denaturing gradient gel electrophoresis. Only exon 6 revealed homo- and heteroduplexes on denaturing gradient gels. Sequencing revealed a substitution of guanine for adenine in the third position of codon 180 that did not change the amino acid encoded. Sequencing of the exon 6-exon 7 splice junction from RNA-polymerase chain reaction amplified cellular RNA of an affected individual revealed that the substitution activates a 5' splice site 24 nucleotides upstream from the normal exon 6-intron 6 boundary. Splicing in two probands' lymphoblasts occurred virtually exclusively at the abnormal 5' splice site created by the codon 180 substitution. Exon 6 sequences from 38 patients and 47 relatives were amplified and analyzed by sequencing or dot-blot hybridization with allele-specific oligonucleotides. The substitution was detected in 74 of 76 Laron syndrome patients' GH-receptor alleles. All 26 parents and 12 of 21 unaffected siblings were heterozygous for this mutation. It was absent in 61 unrelated unaffected control individuals. We conclude that the codon 180 nucleotide substitution probably causes Laron syndrome as translation of the observed, abnormally spliced growth hormone receptor transcript would lead to the synthesis of a receptor protein with an 8 amino acid deletion from the extracellular domain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284474     DOI: 10.1002/humu.1380010105

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

1.  Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene.

Authors:  J Vockley; P K Rogan; B D Anderson; J Willard; R S Seelan; D I Smith; W Liu
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.

Authors:  Jaime Guevara-Aguirre; Priya Balasubramanian; Marco Guevara-Aguirre; Min Wei; Federica Madia; Chia-Wei Cheng; David Hwang; Alejandro Martin-Montalvo; Jannette Saavedra; Sue Ingles; Rafael de Cabo; Pinchas Cohen; Valter D Longo
Journal:  Sci Transl Med       Date:  2011-02-16       Impact factor: 17.956

3.  Diverse growth hormone receptor gene mutations in Laron syndrome.

Authors:  M A Berg; J Argente; S Chernausek; R Gracia; J Guevara-Aguirre; M Hopp; L Pérez-Jurado; A Rosenbloom; S P Toledo; U Francke
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

4.  Genomic features defining exonic variants that modulate splicing.

Authors:  Adam Woolfe; James C Mullikin; Laura Elnitski
Journal:  Genome Biol       Date:  2010-02-16       Impact factor: 13.583

Review 5.  The functional relevance of somatic synonymous mutations in melanoma and other cancers.

Authors:  Valer Gotea; Jared J Gartner; Nouar Qutob; Laura Elnitski; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2015-11       Impact factor: 4.693

6.  Facial morphometry of Ecuadorian patients with growth hormone receptor deficiency/Laron syndrome.

Authors:  G B Schaefer; A L Rosenbloom; J Guevara-Aguirre; E A Campbell; F Ullrich; K Patil; J L Frias
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

7.  Relationship between P561T and C422F polymorphisms in growth hormone receptor gene and mandibular prognathism.

Authors:  Sinem Bayram; Faruk Ayhan Basciftci; Ercan Kurar
Journal:  Angle Orthod       Date:  2014-03-21       Impact factor: 2.079

Review 8.  Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.

Authors:  Jaime Guevara-Aguirre; Camila Bautista; Carlos Torres; Gabriela Peña; Carolina Guevara; Cristina Palacios; Alexandra Guevara; Antonio W D Gavilanes
Journal:  Rev Endocr Metab Disord       Date:  2020-10-12       Impact factor: 6.514

9.  A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization.

Authors:  P Duquesnoy; M L Sobrier; B Duriez; F Dastot; C R Buchanan; M O Savage; M A Preece; C T Craescu; Y Blouquit; M Goossens
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

10.  High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency.

Authors:  Peter Gergics; Cathy Smith; Hironori Bando; Alexander A L Jorge; Denise Rockstroh-Lippold; Sebastian A Vishnopolska; Frederic Castinetti; Mariam Maksutova; Luciani Renata Silveira Carvalho; Julia Hoppmann; Julián Martínez Mayer; Frédérique Albarel; Debora Braslavsky; Ana Keselman; Ignacio Bergadá; Marcelo A Martí; Alexandru Saveanu; Anne Barlier; Rami Abou Jamra; Michael H Guo; Andrew Dauber; Marilena Nakaguma; Berenice B Mendonca; Sajini N Jayakody; A Bilge Ozel; Qing Fang; Qianyi Ma; Jun Z Li; Thierry Brue; María Ines Pérez Millán; Ivo J P Arnhold; Roland Pfaeffle; Jacob O Kitzman; Sally A Camper
Journal:  Am J Hum Genet       Date:  2021-07-15       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.